Using Decision Tools for Mesothelioma: Enhancing Shared Decision-Making
Mesothelioma, caused by asbestos exposure, is a rare and aggressive cancer. It often presents many challenges in diagnosis, treatment, and…
The Role of Surgery in Pleural Mesothelioma
Pleural Mesothelioma is a rare and aggressive cancer caused by asbestos exposure. The outlook for this disease is often poor,…
Mesothelioma Prognosis and Survival Rates: Women and Extended Pleurectomy Decortication
Malignant pleural mesothelioma is a fast-spreading cancer tied to asbestos. Sadly, patients on standard treatments survive just 12–18 months. However,…
MARS 2 Trial: The Future of Pleurectomy Decortication in Pleural Mesothelioma
Malignant pleural mesothelioma, a deadly cancer, often comes from asbestos exposure. It is hard to treat due to its aggressiveness…
Leveraging the Pleural Space for Anticancer Therapies in Pleural Mesothelioma
Malignant pleural mesothelioma is a cancer caused by asbestos. It’s deadly and spreads quickly. It usually appears 30-50 years after…
Malignant Pleural Mesothelioma: Pleural Decortication and Multimodal Therapy
Malignant pleural mesothelioma is a severe cancer caused by asbestos exposure. It impacts the lungs’ lining. Treating it is tough,…
Mesothelioma Treatment: Understanding Cytoreductive Surgery and HIPEC
Peritoneal mesothelioma is a rare cancer linked to asbestos exposure. It’s aggressive. However, a promising option combines cytoreductive surgery (CRS)…
Breaking Through the Treatment Desert of CAR-T Cell Therapy for Malignant Mesothelioma
Malignant mesothelioma is a rare and aggressive cancer caused by asbestos exposure. Treatment options are limited. This is especially true…
Navigating Ipilimumab and Nivolumab Treatment for Mesothelioma: Insights from the United Kingdom
Being diagnosed with mesothelioma is tough. However, it’s vital to know about new treatments and their effects. In the United…
Navigating the Complexities of Immunotherapy for Mesothelioma: Insights for Patients and Caregivers
Mesothelioma is a rare, aggressive cancer that poses challenges for patients and caregivers. Recently, immune checkpoint inhibitors have brought hope…